General Info
Tonghua Dongbao Pharma develops and markets recombinant human insulin for the treatment of diabetes.
Location: Tonghua
Country:
Industries:
Investment Regions: SEA
Investment Stages: late-stage, pre-seed, seed, series-a
Website: http://www.thdb.com/
SEA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-active
AI Reasoning: I searched the company website and news for Tonghua Dongbao Pharmaceutical (通化东宝) and could not find any public record of startup investments, acquisitions, or venture funding in the past year. The site shows company news about revenue and strategic cooperation in 2025 but no investment deals. The most recent corporate activity relates to sales and partnerships (e.g., insulin revenue growth, strategic cooperation announcements) rather than investments into startups such as any specific startup name; no identifiable investment into a named startup was found. Given no evidence of investment activity within the last 12 months, classify as not-active.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Tonghua Dongbao Pharmaceutical
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI